Headache Assessment & Management

Clinical decision support based on Harrison's Ch. 16 (Goadsby) with updated guideline points (AHS 2024, ICHD-3). For clinician use; not a substitute for judgement.

Search the curated reference library. Multiple words narrow results; this search does not diagnose a patient.

1 Red flags2 History3 Result

Red flags (Harrison Table 16-2)

Pattern

Headache days / month

Typical attack duration

Age

Acute analgesic / NSAID days per month

Triptan / opioid / combination days per month

Duration of pattern

Features

Context

Library review: 29 October 2026. Curated local summaries, not a live AI service or an automatically updating guideline feed. Uploaded Ch. 430 excerpts informed the library; original scans are not published.

Sources: Harrison's Principles of Internal Medicine, Ch. 16 Headache (Goadsby); ICHD-3 (Cephalalgia 2018); AHS position statement, CGRP-targeting therapies as a first-line option for migraine prevention (Headache, Mar 2024); AHS consensus statement 2021 (acute and preventive therapy). Doses are typical adult doses; verify against current labels, local formulary and patient factors. Pregnancy, renal/hepatic disease and drug interactions require individual clinical review.